| PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer BA Kansy, F Concha-Benavente, RM Srivastava, HB Jie, G Shayan, Y Lei, ... Cancer research 77 (22), 6353-6364, 2017 | 220 | 2017 |
| ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation FP Vendetti, P Karukonda, DA Clump, T Teo, R Lalonde, K Nugent, ... The Journal of clinical investigation 128 (9), 3926-3940, 2018 | 183 | 2018 |
| A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of … JA Vargo, RL Ferris, J Ohr, DA Clump, KS Davis, U Duvvuri, S Kim, ... International Journal of Radiation Oncology* Biology* Physics 91 (3), 480-488, 2015 | 168 | 2015 |
| Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survival SM Glaser, SF Mandish, BS Gill, GK Balasubramani, DA Clump, S Beriwal Head & neck 38 (S1), E2083-E2090, 2016 | 144 | 2016 |
| Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT MN Theodoraki, S Yerneni, WE Gooding, J Ohr, DA Clump, JE Bauman, ... Oncoimmunology 8 (7), e1593805, 2019 | 142 | 2019 |
| Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma M Kikuchi, DA Clump, RM Srivastava, L Sun, D Zeng, JA Diaz-Perez, ... Oncoimmunology 6 (7), e1329071, 2017 | 109 | 2017 |
| Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus … DC Ling, BV Chapman, J Kim, GW Choby, P Kabolizadeh, DA Clump, ... Oral oncology 61, 41-46, 2016 | 105 | 2016 |
| Transition to a virtual multidisciplinary tumor board during the COVID‐19 pandemic: University of Pittsburgh experience H Dharmarajan, JL Anderson, S Kim, S Sridharan, U Duvvuri, RL Ferris, ... Head & neck 42 (6), 1310-1316, 2020 | 91 | 2020 |
| Initial results of a multicenter phase 2 trial of stereotactic ablative radiation therapy for oligometastatic cancer P Sutera, DA Clump, R Kalash, D D'Ambrosio, A Mihai, H Wang, DP Petro, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 116-122, 2019 | 87 | 2019 |
| Phase Ib study of immune biomarker modulation with neoadjuvant cetuximab and TLR8 stimulation in head and neck cancer to overcome suppressive myeloid signals G Shayan, BA Kansy, SP Gibson, RM Srivastava, JK Bryan, JE Bauman, ... Clinical Cancer Research 24 (1), 62-72, 2018 | 83 | 2018 |
| Role of immunotherapy in head and neck cancer DC Ling, CJ Bakkenist, RL Ferris, DA Clump Seminars in Radiation Oncology 28 (1), 12-16, 2018 | 81 | 2018 |
| Risk of severe toxicity according to site of recurrence in patients treated with stereotactic body radiation therapy for recurrent head and neck cancer DC Ling, JA Vargo, RL Ferris, J Ohr, DA Clump, WYW Yau, U Duvvuri, ... International Journal of Radiation Oncology* Biology* Physics 95 (3), 973-980, 2016 | 74 | 2016 |
| Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases JE Leeman, DA Clump, JC Flickinger, AH Mintz, SA Burton, DE Heron Neuro-oncology 15 (12), 1732-1738, 2013 | 66 | 2013 |
| Radiation oncology and online patient education materials: deviating from NIH and AMA recommendations AV Prabhu, DR Hansberry, N Agarwal, DA Clump, DE Heron International Journal of Radiation Oncology* Biology* Physics 96 (3), 521-528, 2016 | 64 | 2016 |
| Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy ZD Horne, DA Clump, JA Vargo, S Shah, S Beriwal, SA Burton, AE Quinn, ... Radiation Oncology 9, 1-6, 2014 | 64 | 2014 |
| Online palliative care and oncology patient education resources through Google: Do they meet national health literacy recommendations? AV Prabhu, T Crihalmeanu, DR Hansberry, N Agarwal, C Glaser, ... Practical radiation oncology 7 (5), 306-310, 2017 | 52 | 2017 |
| Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer JA Vargo, RL Ferris, DA Clump, DE Heron Frontiers in oncology 4, 214, 2014 | 52 | 2014 |
| Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation K Wang, DE Heron, DA Clump, JC Flickinger, GJ Kubicek, JCM Rwigema, ... Radiotherapy and Oncology 106 (1), 90-95, 2013 | 50 | 2013 |
| Head and neck tumor control probability: radiation dose–volume effects in stereotactic body radiation therapy for locally recurrent previously-irradiated head and neck cancer … JA Vargo, V Moiseenko, J Grimm, J Caudell, DA Clump, E Yorke, J Xue, ... International Journal of Radiation Oncology* Biology* Physics 110 (1), 137-146, 2021 | 47 | 2021 |
| Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer JA Vargo, GJ Kubicek, RL Ferris, U Duvvuri, JT Johnson, J Ohr, DA Clump, ... The Laryngoscope 124 (7), 1579-1584, 2014 | 47 | 2014 |
